BioAge Labs, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for metabolic diseases by targeting the biology of human aging. BioAge Labs, Inc. advances a pipeline of product candidates designed to address conditions such as obesity and other age-associated disorders, using human data and molecular insights to identify drug targets linked to healthy aging. Its current programs include orally available small-molecule candidates and inhibitors aimed at cardiometabolic and neuroinflammatory disease pathways. The company’s work spans therapeutic development in obesity, cardiovascular risk, retinal disorders, and other metabolic indications, positioning it as a research-driven participant in the biotechnology sector. BioAge Labs, Inc. operates with a translational approach that connects aging biology to drug discovery, supporting the development of medicines intended to treat diseases with common biological mechanisms.
United States
EMERYVILLE, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ('BioAge', 'the Company'), a clinical-stage biotechnolog...
Detailed price information for Freeport-Mcmoran Inc (FCX-N) from The Globe and Mail including charting and trades.
Randomized, controlled, approximately 180-participant trial evaluates oral BGE-102 as monotherapy and in combination with anti-VEGF therapyPrimary...
BioAge's diversified pipeline includes ophthalmology and apelin-APJ pathway programs, and partnerships with Novartis and Eli Lilly. See why BIOA stock is a buy.
EMERYVILLE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ('BioAge', 'the Company'), a clinical-stage biotechnolog...
Detailed price information for Fiserv Inc (FISV-Q) from The Globe and Mail including charting and trades.
Investors talking about BIOA also mention
What share of all ETF conversation is about BIOA?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0.01% +0 | 0.02% new | 0% 0 | 0% +0 |
Of the messages about BIOA that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | 95.92% | 95.92% +36.83 | 82.89% +7.72 | ||
| Bearish | — | 4.08% | 4.08% -36.83 | 17.11% -7.72 |
Of the messages about BIOA that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Technical Analysis | — | — | 100% | 75.14% | ||
| Macro | — | — | 0% | 24.86% |
Of the messages about BIOA, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 0% | 3.3% | 2.97% | 36.66% | ||
| Newcomers | 100% | 96.7% | 97.03% | 63.34% |